Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.
about
The cellular and molecular basis for malaria parasite invasion of the human red blood cellMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaInvestigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical ApproachAntibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytesPlasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domainsImproved in vitro culture of Plasmodium falciparum permits establishment of clinical isolates with preserved multiplication, invasion and rosetting phenotypesComplement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparumRevealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytesStructural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formationMalaria Parasites: The Great EscapeA phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparumComplement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand.Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultsThe relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites.Nuclear repositioning precedes promoter accessibility and is linked to the switching frequency of a Plasmodium falciparum invasion geneHost age and expression of genes involved in red blood cell invasion in Plasmodium falciparum field isolates.Changes in parasite virulence induced by the disruption of a single member of the 235 kDa rhoptry protein multigene family of Plasmodium yoelii.Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysQuantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children.High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.Complement receptor 1 and malaria.Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malariaCritical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity.Multifarious roles of sialic acids in immunity.The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175.Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasitesPlasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes.Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.Immune characterization of Plasmodium falciparum parasites with a shared genetic signature in a region of decreasing transmission
P2860
Q21032502-744C56DC-81C0-4D16-B44D-B3C0AC2FFF95Q26772878-32D295E6-D789-468E-A631-378B94B5813BQ26799717-71EDC407-AD9B-4EC6-95D6-5DE49B45CDD8Q27230046-1B8BE588-D686-40EF-8350-C788956A348DQ27230103-A3936741-B4C1-4298-92D7-DDF41BF0163EQ27310757-19D74833-438C-4334-8A05-25009AE33E4EQ27314003-A6F618CF-C87E-4D4B-B5DB-A5A6E8ABBA1AQ27321307-29A35A1A-8008-4F5A-B317-5653452F42D3Q27678372-AB1E2F52-500D-450D-9735-4CAF10A26B17Q27974527-A459331E-27AC-4204-A0A1-A0AE9CC342DAQ28080325-21DDE959-7A1A-424C-8A4C-7968873B6586Q28744696-471CA9A4-DCDE-4CFE-A073-2ED89ADD74DCQ30043132-316553E4-ACD7-4975-B07D-D425D33EAB3FQ30043671-77086DBC-72C6-4C10-9229-A6FAA065FC09Q30425504-144BD3F3-F965-46AA-9681-F1CD89A4F23FQ33380204-E40DBADD-D108-413D-97D6-9AA3E4437FB1Q33380213-04314183-A689-4547-B4E6-55D97AEF4A0CQ33526349-3F99C748-4FD9-476A-97FC-8973BAE740DFQ33582015-1C9FB7FB-41B7-4D63-8182-A60F0FA7F459Q33791381-97BC36BD-82D6-40F7-A528-013BAE0C97E7Q33876022-E5393A46-D545-4D87-9598-F1989EC34EF0Q33916295-1D8257A6-D96E-4A08-9C59-4DFDD339B6A1Q33939788-4E69E982-31B6-41B6-9159-FE0BACDEBDA1Q34081745-3038A6BB-793F-43FA-BAF5-D4331387E216Q34160113-C167F7CA-3640-4CB1-A546-9967A2904F0DQ34171724-BCBBAF9C-B33E-414F-B6BB-A4F6926D5BAFQ34203662-97B6F794-25A9-41C1-B438-09725C308470Q34233738-59C623C2-8285-4A66-AFC0-4AFE802C9071Q34236565-DCE35164-5BB4-42D8-A1C3-D74DBBF9C7D1Q34237880-34A2DF71-523D-489E-9166-A3A275AA53BDQ34270155-B6F24EB3-40A2-4E65-87D3-7BFCDF59AE1AQ34428497-0DC053DD-4696-4E86-B1CB-4BCE2EABB7D0Q34507190-CC779025-C028-4BE9-BCF4-BEA85711C641Q34515219-4D2EB4BC-317B-436D-B167-52F51921082FQ34596157-5317D92B-DD3A-46B2-98D4-BA33EA387032Q34606720-FC808C4F-895A-455E-82C0-1F83B20B6058Q34739631-0DD72DF4-0983-4918-95F3-C6C14FA79F23Q34758376-258E68E2-2E72-498E-AACD-6E38A096907EQ34827195-D7F80F6E-A8F2-4262-BFE3-7A3BD32EE436Q34889810-A19092B0-0DBC-45A0-B81F-60C1CDBB19FA
P2860
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@ast
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@en
type
label
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@ast
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@en
prefLabel
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@ast
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@en
P2093
P2860
P50
P356
P1476
Variation in use of erythrocyt ...... f human inhibitory antibodies.
@en
P2093
Fiona J McCallum
Janine Stubbs
Kristina E M Persson
Linda Reiling
Nicole A Lister
P2860
P304
P356
10.1172/JCI32138
P407
P577
2008-01-01T00:00:00Z